Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
The Role of B-Cell Depletion in MS Care
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
David Weisman, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Uncovering TK2d: How to Navigate Diagnostic Challenges
The New Era of Targeted Therapy for Myasthenia Gravis
New Therapies, New Strategy: Rethinking MG Inpatient Care
Qihua Fan, MD
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Discharge Planning After Myasthenic Crisis
Outcome Measures Capture Progression in Late-Onset TK2d
ADHD Medication Dose-Effect Patterns Vary by Age and Drug Class
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.